KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 88 filers reported holding KRONOS BIO INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $533,562 | -22.2% | 410,317 | +2.9% | 0.00% | – |
| Q2 2023 | $685,784 | -38.9% | 398,712 | -48.1% | 0.00% | – |
| Q1 2023 | $1,122,154 | +93257.2% | 768,599 | +3.5% | 0.00% | – |
| Q4 2022 | $1,202 | -100.0% | 742,512 | +0.9% | 0.00% | – |
| Q3 2022 | $2,464,000 | -9.4% | 735,573 | -1.5% | 0.00% | – |
| Q2 2022 | $2,719,000 | -48.2% | 746,982 | +3.0% | 0.00% | -100.0% |
| Q1 2022 | $5,244,000 | -47.1% | 725,423 | -0.5% | 0.00% | 0.0% |
| Q4 2021 | $9,909,000 | -34.8% | 729,148 | +0.5% | 0.00% | -50.0% |
| Q3 2021 | $15,208,000 | +34.8% | 725,608 | +54.0% | 0.00% | 0.0% |
| Q2 2021 | $11,281,000 | +43.3% | 471,023 | +75.2% | 0.00% | +100.0% |
| Q1 2021 | $7,871,000 | +4.7% | 268,920 | +6.9% | 0.00% | 0.0% |
| Q4 2020 | $7,516,000 | – | 251,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $4,037,358 | 5.52% |
| Omega Fund Management, LLC | 3,818,283 | $5,574,693 | 3.64% |
| Nextech Invest Ltd. | 1,451,537 | $2,119,244 | 0.88% |
| Wildcat Capital Management, LLC | 1,297,959 | $1,895,020 | 0.70% |
| Privium Fund Management (UK) Ltd | 292,182 | $455,804 | 0.36% |
| CM Management, LLC | 180,000 | $263 | 0.31% |
| Artal Group S.A. | 1,542,954 | $2,253 | 0.13% |
| Alphabet Inc. | 1,438,232 | $2,099,819 | 0.12% |
| Perceptive Advisors | 1,752,745 | $2,558,131 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 406,362 | $593 | 0.06% |